Today: 29 April 2026
Liontown (ASX:LTR) share price slides 8.6% as LG Energy plans stake exit — what traders watch next
26 February 2026
1 min read

Liontown (ASX:LTR) share price slides 8.6% as LG Energy plans stake exit — what traders watch next

Sydney, Feb 26, 2026, 17:01 AEDT — Market closed

  • Liontown ended the session at A$1.815, slipping 8.6%. That follows a big jump the day before.
  • LG Energy Solution put its 7.5% Liontown stake up for grabs in a discounted block trade
  • Attention now turns to shareholder filings and Liontown’s half-year results due March 11.

Shares of Liontown Limited ended Thursday down 8.6% at A$1.815, snapping back from a 9.4% jump the previous session. The stock kicked off at A$1.90, ranged between A$1.78 and A$1.91 through the day. Turnover surged, clocking in around 308.8 million shares, Investing.com data showed.

News broke that South Korea’s LG Energy Solution is unloading its 7.5% stake in Australian lithium player Liontown Resources through an after-hours block trade, a term sheet reviewed by Reuters showed. LG is offering 239.5 million shares priced between A$1.75 and A$1.79 apiece, equating to a minimum of A$419 million ($298 million). The term sheet listed the final price as coming later on Wednesday. That range represents a 9.8% to 11.8% discount from Liontown’s last traded price. LG is Liontown’s third-biggest shareholder, after Gina Rinehart’s Hancock Prospecting and chairman Tim Goyder.

Block trades—big chunks of shares, typically unloaded by institutions—move fast, sometimes all at once, sometimes over a couple of hours. When a seller ditches a strategic position, the deal can establish a fresh reference price.

Liontown closed just barely over the upper limit of its marketed range. Traders, eyeing A$1.75 to A$1.79, drew a tentative boundary ahead of Friday.

Heavy trading points to a lot of shares moving, but so far it’s unclear who picked them up. Should short-term players be on the other side, the stock might remain volatile.

When the buyers are long-only accounts, any overhang from the sale tends to clear out fast. Prices usually edge back toward their earlier levels once talk of the deal subsides.

For Liontown bulls, there’s a real chance that discount just sets the upper limit—rather than marking a floor for the shares. If buyers fail to step up, or if big holders dump more stock, the price could easily slip to the lower end of its range.

At this point, it’s all about the register. Investors are eyeing any substantial-holder filings and keeping tabs on whether trading volumes stay hefty, even once the block has been absorbed.

LG’s term sheet indicated the sale would end its position as a Liontown investor. Markets now await confirmation in official filings—and news on any fresh cornerstone investor.

After the share sale, Liontown’s calendar shows its FY26 half-year results coming up March 11, with the March-quarter numbers due April 30.

Stock Market Today

  • Biotech with $277M Cash Says It Can Fund Operations Through 2028
    April 29, 2026, 2:48 AM EDT. A biotech company reports having $277 million in cash, stating it can finance its operations through 2028. The firm highlights progress in regulatory milestones, including orphan drug designation and fast track status, which aim to expedite drug approvals for rare diseases. These designations often provide special incentives and faster review processes. The company is advancing clinical trials with key drugs in Phase 2b and planning Phase 3 studies, essential for market approval and revenue potential. Its financial position is underpinned by regulatory filings, including registration statements on Form S-1, offering transparency for investors assessing risks and opportunities. This solid cash reserve and regulatory progress support confidence in sustained operations and developmental goals over the coming years.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 29.04.2026

29 April 2026
LIVEMarkets rolling coverageStarted: April 29, 2026, 12:00 AM EDTUpdated: April 29, 2026, 2:55 AM EDT Biotech with $277M Cash Says It Can Fund Operations Through 2028 April 29, 2026, 2:48 AM EDT. A biotech company reports having $277 million in cash, stating it can finance its operations through 2028. The firm highlights progress in regulatory milestones, including orphan drug designation and fast track status, which aim to expedite drug approvals for rare diseases. These designations often provide special incentives and faster review processes. The company is advancing clinical trials with key drugs in Phase 2b and planning Phase 3 studies,
AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

29 April 2026
AST SpaceMobile will hold its first-quarter update call on May 11 after winning FCC approval to deploy a 248-satellite constellation for direct-to-device service. Shares fell 6.8% Tuesday, following the loss of its BlueBird 7 satellite in a failed launch. The company expects insurance to cover the loss and is targeting 45 satellites in orbit by end-2026. Investors are watching launch progress and commercial service timing.
Eli Lilly stock price slips as Zepbound KwikPen FDA nod and Novo trial data keep LLY in focus
Previous Story

Eli Lilly stock price slips as Zepbound KwikPen FDA nod and Novo trial data keep LLY in focus

Lloyds share price edges up as buyback rolls on and BoE rate-cut bets sharpen
Next Story

Lloyds share price edges up as buyback rolls on and BoE rate-cut bets sharpen

Go toTop